Michael R. Lusignan

Array ( [id] => 7216166 [patent_doc_number] => 20050054620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Paricalcitol as a chemotherapeutic agent' [patent_app_type] => utility [patent_app_number] => 10/756890 [patent_app_country] => US [patent_app_date] => 2004-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17817 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054620.pdf [firstpage_image] =>[orig_patent_app_number] => 10756890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7075347 [patent_doc_number] => 20050148615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => '(2S)-amino(phenyl)acetic acid and derivatives as alpha2delta voltage-gated calcium channel ligands' [patent_app_type] => utility [patent_app_number] => 10/752943 [patent_app_country] => US [patent_app_date] => 2004-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4882 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148615.pdf [firstpage_image] =>[orig_patent_app_number] => 10752943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7379029 [patent_doc_number] => 20040220265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide' [patent_app_type] => new [patent_app_number] => 10/747963 [patent_app_country] => US [patent_app_date] => 2003-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10125 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220265.pdf [firstpage_image] =>[orig_patent_app_number] => 10747963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 102280 [patent_doc_number] => 07727977 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-01 [patent_title] => 'Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes' [patent_app_type] => utility [patent_app_number] => 10/541377 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 12889 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 247 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/727/07727977.pdf [firstpage_image] =>[orig_patent_app_number] => 10541377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5711111 [patent_doc_number] => 20060052456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes by increasing the number of islets of langerhans cells' [patent_app_type] => utility [patent_app_number] => 10/541493 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15878 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052456.pdf [firstpage_image] =>[orig_patent_app_number] => 10541493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748496 [patent_doc_number] => 20060111428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Combination of an dpp-iv inhibitor and a ppar-alpha compound' [patent_app_type] => utility [patent_app_number] => 10/537870 [patent_app_country] => US [patent_app_date] => 2003-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8285 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111428.pdf [firstpage_image] =>[orig_patent_app_number] => 10537870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325370 [patent_doc_number] => 20040138209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Treatment of inflammatory disorders with 2,3- benzodiazepines' [patent_app_type] => new [patent_app_number] => 10/727940 [patent_app_country] => US [patent_app_date] => 2003-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19632 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138209.pdf [firstpage_image] =>[orig_patent_app_number] => 10727940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325374 [patent_doc_number] => 20040138210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Method of increasing neutrophil production using 2,3-benzodiazepines' [patent_app_type] => new [patent_app_number] => 10/728286 [patent_app_country] => US [patent_app_date] => 2003-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15418 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138210.pdf [firstpage_image] =>[orig_patent_app_number] => 10728286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7346966 [patent_doc_number] => 20040192669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Novel compounds for use in weight loss and appetite suppression in humans' [patent_app_type] => new [patent_app_number] => 10/718232 [patent_app_country] => US [patent_app_date] => 2003-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 13322 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192669.pdf [firstpage_image] =>[orig_patent_app_number] => 10718232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894459 [patent_doc_number] => 20060002998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Pharmaceutical dosage forms of biguanide-sulfonylurea combinations' [patent_app_type] => utility [patent_app_number] => 10/534908 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6895 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 59 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20060002998.pdf [firstpage_image] =>[orig_patent_app_number] => 10534908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921467 [patent_doc_number] => 20060240048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Pyridine derivatives as cb2 receptor modulators' [patent_app_type] => utility [patent_app_number] => 10/528613 [patent_app_country] => US [patent_app_date] => 2003-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33171 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240048.pdf [firstpage_image] =>[orig_patent_app_number] => 10528613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7200199 [patent_doc_number] => 20050042237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Method for administering a spill resistant pharmaceutical system' [patent_app_type] => utility [patent_app_number] => 10/653149 [patent_app_country] => US [patent_app_date] => 2003-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7040 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042237.pdf [firstpage_image] =>[orig_patent_app_number] => 10653149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7337481 [patent_doc_number] => 20040132806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Pravastatin pharmaceutical formulations and methods of their use' [patent_app_type] => new [patent_app_number] => 10/653415 [patent_app_country] => US [patent_app_date] => 2003-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10607 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132806.pdf [firstpage_image] =>[orig_patent_app_number] => 10653415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5726359 [patent_doc_number] => 20060057119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Biologic skin repair and enhancement' [patent_app_type] => utility [patent_app_number] => 10/525361 [patent_app_country] => US [patent_app_date] => 2003-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2280 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057119.pdf [firstpage_image] =>[orig_patent_app_number] => 10525361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674709 [patent_doc_number] => 20040127409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Method of treatment of psychological conditions by administration of nerve growth factor' [patent_app_type] => new [patent_app_number] => 10/624328 [patent_app_country] => US [patent_app_date] => 2003-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6837 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127409.pdf [firstpage_image] =>[orig_patent_app_number] => 10624328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6911779 [patent_doc_number] => 20050175537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Process, system, and kit for evaluating the relief of the skin with a substrate' [patent_app_type] => utility [patent_app_number] => 10/622825 [patent_app_country] => US [patent_app_date] => 2003-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3779 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20050175537.pdf [firstpage_image] =>[orig_patent_app_number] => 10622825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4552982 [patent_doc_number] => 07820643 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain' [patent_app_type] => utility [patent_app_number] => 10/623431 [patent_app_country] => US [patent_app_date] => 2003-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7493 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820643.pdf [firstpage_image] =>[orig_patent_app_number] => 10623431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7135919 [patent_doc_number] => 20040043918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Apoptosis inducers, caspase cascade activators and anticancer agent' [patent_app_type] => new [patent_app_number] => 10/401147 [patent_app_country] => US [patent_app_date] => 2003-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7991 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043918.pdf [firstpage_image] =>[orig_patent_app_number] => 10401147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6959698 [patent_doc_number] => 20050215609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Novel uses of prostaglandin d2, prostaglandin d2 agonist and prostaglandin d2 antagonist' [patent_app_type] => utility [patent_app_number] => 10/529552 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4033 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215609.pdf [firstpage_image] =>[orig_patent_app_number] => 10529552 [rel_patent_id] =>[rel_patent_doc_number] =>)